Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $2.85 | Prev. Close $2.96 | Circuit Range N/A |
Day Range $2.68 - $2.85 | Year Range $1.37 - $21.00 | Volume 2,053 |
Average Traded $2.78 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $3.10 | $2.96 | -3.58% |
07-Apr-26 | $3.44 | $3.08 | -12.89% |
06-Apr-26 | $3.56 | $3.53 | -5.11% |
02-Apr-26 | $3.75 | $3.72 | -4.12% |
01-Apr-26 | $3.73 | $3.88 | +5.43% |
31-Mar-26 | $3.42 | $3.68 | +6.67% |
30-Mar-26 | $4.29 | $3.45 | -8.24% |